CEO‑Led Buy‑Back: Anika Therapeutics CEO Griffin Stephen D. Adds 12,200 Shares, Signals Confidence Amid Volatile Quarter
CEO Griffin Stephen D.’s recent purchase of 12,200 Anika Therapeutics shares signals bullish confidence in the company’s turnaround, hinting at future growth opportunities.
3 minutes to read